Change assessment
One planned change to your AI device, walked through the FDA's software-change and change-control-plan guidance, with a written reason for every answer.
From $2,500 · within a week of receiving the change description and risk file · quoted for your device · software and AI model changes today, read against the FDA's software-change and change-control-plan guidance
What you get
- The FDA's questions answered in order, each with a written reason from your own documents
- The result the guidance's flowchart points to, worded as the guidance words it
- The change-control plans authorized in your product code, as precedent
PDF and Word, every statement footnoted to its source.
How it works
1
Send one document, free
A one-page reply in two working days on what we see and which service fits.
2
Agree a fixed fee
From $2,500. The fee for your device is fixed in writing before work starts.
3
Receive the deliverable
Your documents under a signed confidentiality agreement; delivered within a week of receiving the change description and risk file.
What we need from you
- A description of the change and the version numbers
- Your risk management file and specifications
- Your authorized change-control plan, if you have one
Is it for you?
Right for you if you are asking
“Does this model update need a new submission, or is it covered by our change-control plan?”
Because
- Every release raises the same question, and a change that needed a new 510(k) and did not get one is the costly answer.
- The FDA's guidance asks specific questions about risk, risk controls and clinical performance; the reasons have to be written down.
- Change-control plans are new: the FDA authorized 104 devices with one in 2025, against 29 in 2024.
Often bought by: ai device companies that retrain or update a cleared model; regulatory leads deciding whether a release needs a new 510(k); companies with an authorized pccp checking a change against it.
Not the right fit if
- The device has no FDA authorization yet: the change questions apply to a device on the market, so start with the Pre-Sub package
- You want the decision made for you: the assessment sets out the guidance's questions and your reasons; your regulatory lead decides
Questions
›Where does the data come from, and how accurate is it?
Software and AI model changes today, read against the FDA's software-change and change-control-plan guidance.
Every figure is traced to the FDA’s own record and dated.
›What doesn't it do?
- A determination — whether a new submission is required is the manufacturer's to decide and the FDA's to judge
- A review of the change's verification or validation data
The FDA decides. Every deliverable says so on its cover.
›What isn't included in the price?
- The FDA's user fees and the annual establishment registration fee, paid by you to the FDA
- Entering the content into eSTAR and sending it through the CDRH Portal, done by your team
- Running tests or studies, or writing their protocols
- Speaking for you to the FDA, in meetings or in writing
›Can a consultant buy it for a client?
Yes, at 20% off, delivered under your firm’s name. How it works for consultants →
What usually comes next
Modification packageDoes our change need a new 510(k)?